Por: Newsweek Health November 10, 2022
A new cancer treatment that trains the patient's own immune system to target tumor cells has been developed and successfully trialed in human cancer patients.The therapy uses the CRISPR-Cas9 system for genetic engineering and paves the way for future advances in personalized cancer treatment.Survival rates vary significantly between different cancer types, ranging from 98 percent for testicular cancer to just 1 percent for pancreatic... + full article
Time USA Health November 11, 2022
Researchers have made an important step forward toward a long-desired goal: using the gene-editing technology to treat cancer. In a , scientists recruited 16 people who had already received standard treatment for their cancer (which included colon, head and neck, lung, skin, and... + más
Starting a Revolution Isn’t Enough | The Atlantic
Personalized cancer treatment edges closer with CRISPR trial success | Newsweek
New York Post USA Life November 11, 2022
Those living with cancer may soon be eligible for the most bespoke treatment to date. New research has the potential to revolutionize the battle against cancer by “editing” patients’ own cells to fight their unique disease profile. As part of a clinical trial, published in... + más
Boston startup Ascidian Therapeutics charts vision for therapies that ‘rewrite RNA’ | The Boston Globe
Portland Press Herald USA Health November 05, 2022
The lone volunteer in a unique study involving a gene-editing technique has died, and those behind the trial are now trying to figure out what killed him. Terry Horgan, a 27-year-old who had Duchenne muscular dystrophy, died last month, according to Cure Rare Disease, a... + más
Death in CRISPR gene therapy study sparks search for answers | ABC News
Death in CRISPR gene therapy study sparks search for answers | Associated Press
Associated Press USA Science November 04, 2022
The lone volunteer in a unique study involving a gene-editing technique has died, and those behind the trial are now trying to figure out what killed him.Terry Horgan, a 27-year-old who had Duchenne muscular dystrophy, died last month, according to Cure Rare Disease, a... + más
ABC News USA Tech November 04, 2022
Ars Technica USA Science October 06, 2022
Navigate Filter by topic Settings Front page layout Site theme Comment activity Sign up or login to join the discussions! Sign up to comment and more - Oct 6, 2022 12:00 pm UTC / A 3D illustration of the HIV virus. Share this story In July, an HIV-positive man became the first... + más
HIV-positive people who have monkeypox are hospitalized more often, CDC study says | CNBC
The Atlantic USA Science September 24, 2022
CRISPR is changing the world—but it can do more.Erik Carter / The AtlanticSeptember 12, 2022Two years ago, I was working on my laptop in an airport lounge in Newark, New Jersey, when I glanced up and saw a couple walking with their two boys. The younger boy slowly made his way... + más
Teenagers on Revolution roster have provided a spark that bodes well for the future | The Boston Globe
‘I Think the Women Are Winning’ | The Atlantic
About iurex | Privacy Policy | Disclaimer |